Antibiotic Resistance Project

About

Copy the URL for use in an RSS reader:

Antibiotic Innovation

The history of antibiotics is cyclical: Drugs are developed, but bacterial evolution can soon render them ineffective in treating infections. Antibiotic resistance is fueled by the injudicious use of existing drugs and compounded by a failure to develop novel new ones. Today there are not enough drugs in development to meet current and anticipated patient needs, with many major pharmaceutical companies limiting or stopping their investments in antibiotic innovation.

Pew works to develop and promote policies that will support the development of new antibiotics to ensure a healthy nation today and in the future. 

Additional Resources

Media Contact

Heather Cable

Antibiotics in Development

Tracking the Pipeline

Identifying each drug, its manufacturer, its potential targets, and where it is in the development process.

Read More